Answers are grounded in this paper and cite their sources.
The comprehensive clinical management of osteosarcoma requires an integrated approach to eradicate malignancies and subsequently reconstruct critical-sized bone defects. Herein, a spatiotemporally responsive therapeutic scaffold (WVM@GM) is engineered by embedding a tungsten-doped vanadium dioxide (W-VO2)/niobium carbide (Nb2C) Schottky heterojunction within a porous gelatin methacryloyl (GelMA). Upon near-infrared II (NIR-II) irradiation, the localized temperature rise triggers the metal–insulator phase transition (MIT) in W-VO2, narrowing the bandgap and strengthening the built-in electric field of the heterostructure. This dynamic electronic modulation effectively elevates the density of carriers under ultrasound (US) irradiation, thereby amplifying reactive oxygen species (ROS) production to achieve a highly efficient sonodynamic therapy (SDT). Following neoplastic clearance, modulating the external physical stimuli shifts the scaffold into a proregenerative mode. Specifically, the engineered biophysical microenvironment synergizes with the mechanical stimulation of low-intensity pulsed ultrasound (LIPUS) to drive bone tissue regeneration. Transcriptomic profiling reveals the activation of focal adhesion, Wnt, and PI3K-Akt signaling pathways, actively regulating the coupling of angiogenesis and osteogenic differentiation. In vivo evaluations validate that this platform effectively ablates tumors and successively rebuilds bone defects. Overall, this photothermally modulated heterojunction strategy establishes a rational and sequential paradigm for osteosarcoma therapy and bone tissue regeneration.
No takes yet. Share an insight, caveat, or question.
Mi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: